Evidence map›Paper›PMID 35380462›Full record

ArticleJournal of bacteriology2022

Glby, Encoded by

Christos Galanis, Emily C Maggioncalda, Pankaj Kumar, Gyanu Lamichhane

Open access · hybridAbstract read
In one paragraph

Article in Journal of bacteriology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Expanding the scope ofbioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Novel C5α-substituted carbapenems enhanceAntimicrobial agents and chemotherapy · 2025
    Article
  6. Durlobactam in combination with β-lactams to combatAntimicrobial agents and chemotherapy · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christos GalanisCenter for Tuberculosis Research, Department of Medicine, School of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Emily C MaggioncaldaCenter for Tuberculosis Research, Department of Medicine, School of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Pankaj KumarCenter for Tuberculosis Research, Department of Medicine, School of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Gyanu LamichhaneCenter for Tuberculosis Research, Department of Medicine, School of Medicine, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.ORCID 0000-0002-2214-0114
Johns Hopkins University · US

Funding

Development of novel penems for drug-resistant tuberculosisR01AI137329 · NIAID · JOHNS HOPKINS UNIVERSITY · PI NUERMBERGER, ERIC L, TOWNSEND, CRAIG ARTHUR · 2018 to 2022
$3.9M
A strategy for new regimens to treat pulmonary Mycobacteroides abscessus infectionR01AI155664 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LAMICHHANE, GYANU · 2020 to 2024
$2.1M
A strategy to treat M. abscessus infectionsR21AI137720 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LAMICHHANE, GYANU · 2019 to 2020
$450k
The Role of Atypical Cell Wall Biology of Mycobacterium abscessus in Pulmonary Infection and TherapyF31HL147392 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MAGGIONCALDA, EMILY · 2019 to 2020
$62k
NHLBI NIH HHS F31 HL147392NIAID NIH HHS R01 AI137329NIAID NIH HHS R01 AI155664NIAID NIH HHS R21 AI137720
6 · The paper itself

Abstract

Mycobacteroides abscessus (

Indexed as

Cystic FibrosisMycobacterium abscessusMycobacterium Infections, NontuberculousAnti-Bacterial Agentsbeta-LactamasesHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesGlbyMAB_3167cMycobacterium abscessusMycobacteroides abscessusβ-lactamase

Identifiers

PMID35380462
PMCPMC9112878
OpenAlexW4226215336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.